Rattan Juneja
Eli Lilly (United States)(US)
Publications by Year
Research Areas
Diabetes Management and Research, Diabetes Treatment and Management, Hyperglycemia and glycemic control in critically ill and hospitalized patients, Diabetes and associated disorders, Pancreatic function and diabetes
Most-Cited Works
- → The Evolution of Insulin and How it Informs Therapy and Treatment Choices(2020)218 cited
- → Utilization of a Computerized Intravenous Insulin Infusion Program to Control Blood Glucose in the Intensive Care Unit(2007)112 cited
- → The Stroke Hyperglycemia Insulin Network Effort (SHINE) Trial Protocol: A Randomized, Blinded, Efficacy Trial of Standard vs. Intensive Hyperglycemia Management in Acute Stroke(2013)101 cited
- → Glucagon‐like peptide‐1 receptor agonists compared with basal insulins for the treatment of type 2 diabetes mellitus: a systematic review and meta‐analysis(2016)95 cited
- → Equivalent insulin resistance in latent autoimmune diabetes in adults (LADA) and type 2 diabetic patients(2007)89 cited
- → Islet cell antibodies and glutamic acid decarboxylase antibodies, but not the clinical phenotype, help to identify type 1[frac12] diabetes in patients presenting with type 2 diabetes(2001)88 cited
- → Cellular immune responses to human islet proteins in antibody-positive type 2 diabetic patients.(1999)87 cited
- → Type 1 1/2 Diabetes: Myth or Reality?(1999)85 cited
- → Computerized intensive insulin dosing can mitigate hypoglycemia and achieve tight glycemic control when glucose measurement is performed frequently and on time(2009)84 cited
- → The Basis for Weekly Insulin Therapy: Evolving Evidence With Insulin Icodec and Insulin Efsitora Alfa(2024)63 cited